Glaukos Corporation Stock Price and Value Analysis

Should you buy Glaukos Corporation stock? (NYSE:GKOS). Let's see how it does in our automated value investing analysis system.

  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.
  • This company pays no dividend.

Inside the GKOS Numbers

GKOS Price
(Glaukos Corporation stock price per share)
[?] PE Ratio versus Sector 470% higher than other Healthcare stocks
[?] PE Ratio versus Industry 379% higher than other Medical Instruments & Supplies stocks
[?] Free Cash Flow Jitter 61%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,983,647 shares shorted. With 45,356,575 shares available for purchase and an average trading volume over the past 10 trading days of 401,440, it would take at least 4.941 days for all of the short holders to cover their shorts.

Is Glaukos Corporation Stock on Sale?

Based on our analysis, we believe that you should not buy Glaukos Corporation right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy GKOS Stock?

Does Glaukos Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.